NOON Aesthetics

NOON Aesthetics is an Israeli professional skincare company founded in 2012 in Tel Aviv [7]. It develops what it calls medical-grade or "paraceutical" formulas built around a proprietary technology named DermShield, which the company says lets its products carry unusually high concentrations of active ingredients while limiting the redness and stinging those actives normally cause. Rather than selling to the public, NOON distributes only through trained skincare professionals such as dermatologists, plastic surgeons and aestheticians, and reports a presence in more than 50 countries.

The brand pairs a chemistry-led product range with a closed professional channel: its formulas are dispensed in clinics and medi-spas rather than on shelves or through its own website. That positioning, together with the DermShield technology and a 2025 global rebrand, defines how NOON presents itself.

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

NOON Aesthetics was established in 2012 by Masha Minkin and Eran Rosman, who according to the brand partnered that year to develop its core technology [5]. The two come from contrasting backgrounds. Minkin, listed as Founder and Chief Technology Officer, studied chemistry and went on to work as a medi-spa owner, researcher and formulator; the company's Science page credits her with developing DermShield. Rosman, Founder and Chief Executive Officer, began his career as an aeronautic and space engineer working on missile-defence systems before moving into the skincare venture.

The founding year of 2012, the Israeli origin and the Tel Aviv headquarters are recorded in a 2020 PR Newswire release and corroborated by a UK stockist profile and trade coverage marking the company's tenth anniversary in 2022 [7][11][12].

NOON positions itself as a science-driven, professional-only skincare house. Its stated mission is to formulate and deliver proprietary technologies for "safe and effective skin care," and the company frames its purpose around the success of its partners — the skincare professionals who use its products and the patients they treat. One line on its philosophy page sums up the stance: products "need to work for the patient, or they don't work for any of us."

Central to that positioning is the claim that effective results and comfort need not be a trade-off. High concentrations of active ingredients are required for strong results, the company argues, while "redness, irritation and discomfort are not." The range is organised into four categories — Cleanse and Prepare, Correct, Soothe and Hydrate, and Protect — and NOON classifies products against skin concerns using a short acronym system covering aging, brightening, acne, dry skin, rosacea and seborrhea.

Distribution is a defining feature rather than an afterthought. NOON states that its products are available only through a network of authorised providers and that it does not sell on its own website; a 2020 press release likewise described the line as "not available in any retail channels or online shops" [7]. Third-party distributors echo this, summarising the brand as exclusive to professionals and never sold online.

The brand is built around DermShield, the proprietary technology it presents as the reason its formulas can hold high-strength actives without the usual irritation. NOON describes the mechanism in neurological terms: DermShield "reduces the intensity of the electrical impulse of the C-Fiber, thereby suppressing adverse side effects," and works by temporarily inhibiting the skin's chemical-sensitive receptors, the Type C nociceptors that signal stinging and inflammation [3][4].

The active ingredients carried at high concentration include azelaic acid, glycolic acid, lactic acid, salicylic acid and retinol [3]. The company cites clinical support for the technology: it points to a study published in the December 2021 issue of The Journal of Drugs in Dermatology, which it says concluded that DermShield is a "highly effective, safe modality in the reduction of erythema, pain and itching" following superficial chemical peels [3]. NOON also reports that in a 50% glycolic acid peel, neurogenic inflammation was reduced by 95% [4]. These figures are the company's own account of the research rather than an independent assessment.

The harvest record flagged "DST" or "Diffusal System Technology" as a possible alternative name for the technology, but the brand's own pages and every third-party source reviewed refer to it only as DermShield; the alternative name was not confirmed by any source [3].

After its 2012 founding, NOON expanded internationally and entered the United States, launching NOON Aesthetics, Inc. on 1 December 2020 [7]. In 2022 the company marked its tenth anniversary with new skincare products and established a US sales operation [12].

In 2025 NOON undertook a rebranding — a new logo and packaging — alongside an expanded product line aimed at both home and professional use, presented at two industry events: the Aesthetic and Anti-Aging Medicine World Congress (AMWC) in Monaco in late March and the AmSpa gathering in Las Vegas in April [10]. Chief Executive Eran Rosman described the change as more than a new logo, framing it as a commitment to "advancing skincare through education, scientific innovation, and exceptional customer service." Even with the expanded home-care range, the products continued to be sold only through professionals and clinics.

NOON Aesthetics is active. Its most recent visible activity is the 2025 rebrand and product launches at international congresses, and the company reports distribution across more than 50 countries. Independent coverage from authorised distributors, including a 2025 launch in the Canadian market, points to continued expansion. Consumer beauty press coverage is limited, which is consistent with the brand's professional-only model; third-party perspective comes mainly from authorised distributors and trade publications rather than mainstream beauty media.